Sera Prognostics SERA Cash, Cash Equivalents, and Marketable Securities
Cash, Cash Equivalents, and Marketable Securities at other companies
Other financials
Where this comes from
Reported directly by Sera Prognostics in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition.
The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sera Prognostics's cash, cash equivalents, and marketable securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sera Prognostics's cash, cash equivalents, and marketable securities?
- Sera Prognostics (SERA) reported cash, cash equivalents, and marketable securities of $36.86M in Q1 2026.
- How has Sera Prognostics's cash, cash equivalents, and marketable securities changed year-over-year?
- Sera Prognostics's cash, cash equivalents, and marketable securities decreased by 0.6% year-over-year, from $37.1M to $36.86M.
- What is the long-term trend for Sera Prognostics's cash, cash equivalents, and marketable securities?
- Over 4 years (2021 to 2025), Sera Prognostics's cash, cash equivalents, and marketable securities has grown at a -36.3% compound annual growth rate (CAGR), from $81.03M to $13.36M.
- What does cash, cash equivalents, and marketable securities mean?
- This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term investments that can be readily converted into cash. It serves as the primary buffer for operational liquidity and potential capital allocation activities. Investors monitor this to assess the company's ability to meet short-term obligations and fund growth initiatives.